Please try another search
Monsenso A/S develops and sells digital health solution for the treatment of mental disorders. It offers Monsenso app for individuals that help them in the areas of self-assessments and questionnaires, sensor data collection from phones and wearables, reminders on medication and sessions, visualizations and motivational feedback, psychoeducation and cognitive behavioral therapy, and secure messaging; and app for carers that help them in the areas of self-assessments, questionnaires, psychoeducation, and a range of learning tools. The company provides clinical web portal for clinicians enable users for the visualization of patient data, patient dashboard, historical overview, correlation analysis, notes/medical record keeping, messaging, and shared decision-making; and data analytics for clinicians for historical aggregation of health and behavioral data, statistical descriptors, correlation between behavioral data and illness progression, pattern analysis, predictive analytics and mood forecasting, and risk assessment. It serves patients, clinicians, healthcare systems and researchers, and carers. Monsenso A/S was founded in 2013 and is based in Frederiksberg, Denmark.
Name | Age | Since | Title |
---|---|---|---|
Jakob Eyvind Bardram | 56 | 2018 | Co-Founder & Vice Chairman of the Board |
Jacob Hahn Michelsen | 58 | 2021 | Director |
Claus Stie Kallesoe | - | 2022 | Director |
Peter Morch Eriksen | 64 | 2022 | Chairman |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review